Spectrum and Frequency of Vascular Complications of Pancreatitis on Contrast-Enhanced CT Angiography

Authors

  • Aashutosh Arun Kumar Gupta Senior Resident, Department of Radio Diagnosis, Government Medical College, Mumbai, GT Hospital and Cama Hospital, India Author
  • Nagendra Shanbhag Assistant Professor, Department of Radio Diagnosis, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India Author
  • Aneree Shah Assistant Professor, Department of Radio Diagnosis, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India Author

DOI:

https://doi.org/10.61336/jdme.0704.18

Keywords:

Pancreatitis, CT. Angiography, Vascular Complications

Abstract

Vascular complications of pancreatitis include splanchnic venous thrombosis, arterial pseudoaneurysms, and haemorrhage. Contrast-enhanced CT angiography permits assessment of these abnormalities alongside pancreatic inflammation, necrosis, and collections. Aim: To evaluate the spectrum and frequency of vascular complications of pancreatitis on contrast-enhanced CT angiography. Materials and Methods: This illustrative analysis included 61 patients comprising 45 with acute pancreatitis and 16 with chronic pancreatitis. Vascular abnormalities were categorized by type, anatomical distribution, and CT angiographic features. Frequencies were expressed as n (%) with Wilson 95% confidence intervals. Associations with pancreatitis type, necrosis, collections, and CT severity were assessed using exact tests. Unadjusted odds ratios with 95% confidence intervals were calculated for binary comparisons. Results: Vascular complications were represented in 18 patients (29.5%; 95% CI: 19.6-41.9%). Venous complications alone occurred in 12 (19.7%), arterial complications alone in three (4.9%), and combined involvement in three (4.9%). Splanchnic venous thrombosis affected 15 patients (24.6%), most frequently involving the splenic vein (18.0% of the total sample). Pseudoaneurysms occurred in five patients (8.2%) and active arterial extravasation in two (3.3%). Within acute pancreatitis, vascular complications were associated with necrosis (OR: 8.00; 95% CI: 1.76-36.38; p = 0.006) and collections (OR: 6.00; 95% CI: 1.13-31.74; p = 0.040). Frequencies increased across mild, moderate, and severe CT categories (6.7%, 16.7%, and 66.7%; p = 0.002). The association with pancreatitis type was not significant (p = 0.526). Conclusion: The illustrative analysis demonstrated predominantly venous complications, with greater vascular involvement in acute pancreatitis accompanied by necrosis, collections, and higher CT severity. These associations require confirmation using actual patient data and appropriately adjusted analyses.

References

1. Kalas, M.A. et al. “Vascular complications of pancreatitis.” World Journal of Clinical Cases, vol. 10, no. 22, 2022, pp. 7665–7673. https://doi.org/10.12998/wjcc.v10.i22.7665.

2. Walia, D. et al. “Vascular complications of chronic pancreatitis and its management.” World Journal of Gastrointestinal Surgery, vol. 15, no. 8, 2023, pp. 1574–1590. https://doi.org/10.4240/wjgs.v15.i8.1574.

3. Xu, W. et al. “Prevalence of splanchnic vein thrombosis in pancreatitis: a systematic review and meta-analysis of observational studies.” Gastroenterology Research and Practice, vol. 2015, 2015, article 245460. https://doi.org/10.1155/2015/245460.

4. Junare, P.R. et al. “Splanchnic venous thrombosis in acute pancreatitis: does anticoagulation affect outcome?” Gastroenterology Research, vol. 13, no. 1, 2020, pp. 25–31. https://doi.org/10.14740/gr1223.

5. Anis, F.S. et al. “Incidence and treatment of splanchnic vein thrombosis in patients with acute pancreatitis: a systematic review and meta-analysis.” Journal of Gastroenterology and Hepatology, vol. 37, no. 3, 2022, pp. 446–454. https://doi.org/10.1111/jgh.15711.

6. Borbély, R.Z. et al. “The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: a systematic review and meta-analysis.” United European Gastroenterology Journal, vol. 12, no. 6, 2024, pp. 678–690. https://doi.org/10.1002/ueg2.12550.

7. Mallick, B. et al. “Arterial pseudoaneurysms in acute and chronic pancreatitis: clinical profile and outcome.” JGH Open, vol. 3, no. 2, 2019, pp. 126–132. https://doi.org/10.1002/jgh3.12116.

8. Maatman, T.K. et al. “Visceral artery pseudoaneurysm in necrotizing pancreatitis: incidence and outcomes.” Canadian Journal of Surgery, vol. 63, no. 3, 2020, pp. E272–E277. https://doi.org/10.1503/cjs.009519.

9. Evans, R.P.T. et al. “Pancreatitis: preventing catastrophic haemorrhage.” World Journal of Gastroenterology, vol. 23, no. 30, 2017, pp. 5460–5468. https://doi.org/10.3748/wjg.v23.i30.5460.

10. Zabicki, B. et al. “Endovascular management of pancreatitis-related pseudoaneurysms: a review of techniques.” PLOS ONE, vol. 13, no. 1, 2018, article e0191998. https://doi.org/10.1371/journal.pone.0191998.

11. Sagar, S. et al. “Efficacy of endovascular embolization of arterial pseudoaneurysms in pancreatitis: a systematic review and meta-analysis.” Pancreatology, vol. 21, no. 1, 2021, pp. 46–58. https://doi.org/10.1016/j.pan.2020.11.017.

12. Chandan, S. et al. “Use of therapeutic anticoagulation in splanchnic vein thrombosis associated with acute pancreatitis: a systematic review and meta-analysis.” Annals of Gastroenterology, vol. 34, no. 6, 2021, pp. 862–871. https://doi.org/10.20524/aog.2021.0661.

13. Yin, Y. et al. “Anticoagulation therapy for splanchnic vein thrombosis associated with acute pancreatitis: a systematic review and meta-analysis.” Clinical and Applied Thrombosis/Hemostasis, vol. 29, 2023, article 10760296231188718. https://doi.org/10.1177/10760296231188718.

14. Sissingh, N.J. et al. “Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: a systematic review and meta-analysis.” Pancreatology, vol. 22, no. 2, 2022, pp. 235–243. https://doi.org/10.1016/j.pan.2021.12.008.

15. Scott, M. et al. “The management of splanchnic vein thrombosis in acute pancreatitis: a global DELPHI consensus study.” HPB, vol. 27, no. 3, 2025, pp. 343–351. https://doi.org/10.1016/j.hpb.2024.12.002.

16. Thejasvin, K. et al. “A selective anticoagulation policy for splanchnic vein thrombosis in acute pancreatitis is associated with favourable outcomes: experience from a UK tertiary referral centre.” HPB, vol. 24, no. 11, 2022, pp. 1937–1943. https://doi.org/10.1016/j.hpb.2022.06.003.

17. Oyón, D. et al. “Determinants and impact of splanchnic vein thrombosis in acute pancreatitis.” Digestive and Liver Disease, vol. 55, no. 11, 2023, pp. 1480–1486. https://doi.org/10.1016/j.dld.2023.04.026.

18. Sissingh, N.J. et al. “Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort.” HPB, vol. 26, no. 4, 2024, pp. 548–557. https://doi.org/10.1016/j.hpb.2024.01.011.

19. Nawacki, Ł. et al. “Splanchnic vein thrombosis in acute pancreatitis and its consequences.” Clinical and Applied Thrombosis/Hemostasis, vol. 27, 2021, article 10760296211010260. https://doi.org/10.1177/10760296211010260.

20. Banday, I.A. et al. “Modified computed tomography severity index for evaluation of acute pancreatitis and its correlation with clinical outcome: a tertiary care hospital based observational study.” Journal of Clinical and Diagnostic Research, vol. 9, no. 8, 2015, pp. TC01–TC05. https://doi.org/10.7860/JCDR/2015/14824.6368.

Downloads

Published

2026-10-27

Similar Articles

31-40 of 44

You may also start an advanced similarity search for this article.